CHRU de Brest
Brest, Finistère, 29200, France
NCT Number: NCT04200196
The purpose of this study is to demonstrate an anxiety decrease about children 3 to 6 years during a venous puncture with the "fabrique à histoire".
Looking for future studies?
Notify Me3 year–6 year
All sexes
Interventional
Not applicable
Brest, Finistère, 29200, France
The purpose of this study is to demonstrate an anxiety decrease about children 3 to 6 years during a venous puncture with the "fabrique à histoire".
the study will compare the "fabrique à histoire"(Lunii(R)) with the usual care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
"Fabrique à histoire" is a participatory entertainment method. Children of this arm going to create and listening a story before and during the venous puncture.
It is a passive entertainment method. Children of this arm going to do habitual activities before and during the venous puncture, like to sing, blow up a balloon, to play with recreational thing, etc.
Time frame: During venipuncture, an average of 1,5 hours
Evolution of mYPAS (validated anxiety scale with a scale 23,3 (no anxiety) to 100 (max of anxiety) between T0 (before venipuncture) and T1 (venipuncture). mYPAS is quoted by an extern observator
Time frame: through study completion, an average of 2 hours
Evolution of mYPAS (validated anxiety scale with a scale 23,3 (no anxiety) to 100 (max of anxiety) between T0 and T2 (after venipuncture). mYPAS is quoted by an extern observator.
Time frame: through study completion, an average of 2 hours
Evolution of Self-assessment of pain with the face scale caused by the venous puncture for children 4 to 6 years between T0 and T2 (after venipuncture)
Time frame: through study completion, an average of 2 hours
Evolution assessment of pain caused by the venous puncture for children assess by caregivers and measured with FLACC Scale (Face Legs Activity Cry Consolability / 0=no pain and 10=max pain) between T0 and T2 (after venipuncture)
Time frame: through study completion, an average of 2 hours
Assessment of anxiety caused by the venous puncture for children assess by parents at T2 with an Analogue and Visual Scale (AVS) 10 levels (0=No anxiety 10=max anxiety)
Time frame: through study completion, an average of 2 hours
Assessment of pain caused by the venous puncture for children assess by parents at T2 with an AVS 10 level (0=No pain 10=max pain)
Time frame: through study completion, an average of 2 hours
Number of venous puncture tentative(s) before success
Time frame: through study completion, an average of 2 hours
Success or not (Yes/No) of the venous puncture
Time frame: through study completion, an average of 2 hours
Measure of time spent performing the act before its success
Time frame: through study completion, an average of 2 hours
Assessment of caregivers feedback from the gesture with an AVS 0 (worst feeling) to 10 (best feeling)
Time frame: through study completion, an average of 2 hours
Assessment of parents feedback from the gesture with an AVS 0 (worst feeling) to 10 (best feeling)
University Hospital, Brest
Other
Improvement of Anxiety Management During a Venous Puncture About Children 3 to 6 Years, with a Participatory Entertainment Method
Acronym: PEDIPAIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03100279
Anxiety Disorders, Behavior
Piscataway, New Jersey, United States
View Trial DetailsNCT01829100
Anxiety Disorders, Depressive Disorder
Piscataway, New Jersey, United States
View Trial DetailsNCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05927987
Anxiety Disorders, Depressive Disorder
Amsterdam, Netherlands
View Trial Details